公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2005 | Early restaging whole-body 18F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma | RUOH-FANG YEN ; Chen, Tony Hsiu Hsi ; Ting L.-L.; KAI-YUAN TZEN ; Pan M.-H.; RUEY-LONG HONG | European Journal of Nuclear Medicine and Molecular Imaging | 45 | 38 | |
2004 | Effect of 5-Aminolevulinic Acid-Mediated Photodynamic Therapy on MCF-7 and MCF-7/ADR Cells | Tsai, Tsuimin; RUEY-LONG HONG ; JUI-CHANG TSAI ; PEI-JEN LOU ; Ling, I-Fang; Chen, Chin-Tin | Lasers in Surgery and Medicine | 75 | 62 | |
1996 | Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: A retrospective analysis covering a 34-year period | Chen H.H.W.; Fong L.; Su I.-J.; Ting L.-L.; RUEY-LONG HONG ; Leung H.W.C.; Lui L.T. | Radiotherapy and Oncology | 36 | 32 | |
1995 | Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas | RUEY-LONG HONG ; WEN-JENG LEE ; CHIA-TUNG SHUN ; Chu J.-S.; YAO-CHANG CHEN | Oncology | 52 | 47 | |
1995 | Expressions of E-Cadherin and Exon V6-Containing Isoforms of CD44 and their Prognostic Values in Human Transitional Cell Carcinoma | RUEY-LONG HONG ; YEONG-SHIAU PU ; Hsieh T.-S.; Chu J.-S.; Lee W.-J. | The Journal of Urology | 55 | 55 | |
2001 | Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases | Hsu M.-M; RUEY-LONG HONG ; Ting L.-L; JENG-YUH KO ; Sheen T.-S; PEI-JEN LOU | Archives of Otolaryngology - Head and Neck Surgery | 50 | 43 | |
2012 | Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy | ZHONG-ZHE LIN ; CHIUN HSU ; Hu F.-C.; YU-YUN SHAO ; DWANG-YING CHANG ; CHIH-HSIN YANG ; RUEY-LONG HONG ; CHIH-HUNG HSU ; ANN-LII CHENG | Oncologist | 8 | 10 | |
2008 | Fatal thrombocytopenia after oxaliplatin-based chemotherapy | YU-YUN SHAO ; RUEY-LONG HONG | Anticancer Research | 19 | 20 | |
2018 | Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study | RUEY-LONG HONG ; Hsiao C.F.; Ting L.L.; JENG-YUH KO ; CHUN-WEI WANG ; Chang J.T.C.; PEI-JEN LOU ; Wang H.M.; Tsai M.H.; Lai S.C.; Liu T.W. | Annals of Oncology | 98 | 92 | |
2018 | A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing | Lizotte P.H.; RUEY-LONG HONG ; Luster T.A.; Cavanaugh M.E.; Taus L.J.; Wang S.; Dhaneshwar A.; Mayman N.; Yang A.; Kulkarni M.; Badalucco L.; Fitzpatrick E.; HSIANG-FONG KAO ; Kuraguchi M.; Bittinger M.; Kirschmeier P.T.; Gray N.S.; Barbie D.A.; Janne P.A. | Cancer Immunology Research | 59 | 53 | |
2017 | Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate-cysteine ligase catalytic subunit in head and neck squamous cell carcinoma | Liu C.-W.; KUO-TAI HUA ; Li K.-C.; HSIANG-FONG KAO ; RUEY-LONG HONG ; JENG-YUH KO ; Hsiao M.; Kuo M.-L.; CHING-TING TAN | Molecular Cancer Therapeutics | 42 | 40 | |
1992 | Hodgkin's disease and non-hodgkin's lymphoma containing reed-sternberg-like giant cells in Taiwan: A clinicopathologic analysis of 50 cases | RUEY-LONG HONG ; Su I.-J.; YAO-CHANG CHEN ; Hsieh H.-C.; Wang C.-H.; Liu C.-H.; MING-CHING SHEN | Cancer | 7 | 8 | |
2013 | Identification of novel mutations of TP53, ALK and RET gene in metastatic thymic squamous cell carcinoma and its therapeutic implication | Hu Z.; Wang J.; Yao T.; RUEY-LONG HONG ; Zhang K.; Gao H.; Wu X.; Li J.; Bai C.; Yen Y. | Lung Cancer | 6 | 6 | |
2020 | The impacts of intra-arterial chemotherapy on head and neck microvascular reconstruction | CHEN-HSIANG KUAN ; Chung M.-J.; RUEY-LONG HONG ; Tseng T.-Y.; HAO-CHIH TAI ; NAI-CHEN CHENG ; JUNG-HSIEN HSIEH ; SHYUE-YIH HORNG ; HONG-SHIEE LAI | Journal of the Formosan Medical Association | 2 | 1 | |
2024 | Improved outcomes of localized diffuse large B-cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era | WEI-LI MA ; RUEY-LONG HONG ; PEI-JEN LOU ; MING YAO ; SHANG-JU WU ; CHUNG-WU LIN ; CHUN-WEI WANG ; Chang, Chin-Hao; ANN-LII CHENG ; SUNG-HSIN KUO | Cancer medicine | 0 | 0 | |
2001 | Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma | RUEY-LONG HONG ; Ting L.-L.; JENG-YUH KO ; Hsu M.-M.; Sheen T.-S.; PEI-JEN LOU ; CHIA-CHUN WANG ; Chung N.-N.; Lui L.T. | Journal of Clinical Oncology | 96 | 86 | |
1999 | Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study | RUEY-LONG HONG ; Sheen T.S.; JENG-YUH KO ; Hsu M.M.; CHIA-CHUN WANG ; Ting L.L. | British Journal of Cancer | 32 | 32 | |
2017 | Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma | JENNY LING-YU CHEN ; YU-SEN HUANG ; SUNG-HSIN KUO ; RUEY-LONG HONG ; JENG-YUH KO ; PEI-JEN LOU ; CHUN-WEI WANG | Oncotarget | 17 | 15 | |
2013 | Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma: Treatment results and locoregional recurrence | JENNY LING-YU CHEN ; YU-SEN HUANG ; SUNG-HSIN KUO ; YA-FANG CHEN ; RUEY-LONG HONG ; JENG-YUH KO ; PEI-JEN LOU ; CHIAO-LING TSAI ; WAN-YU CHEN ; CHUN-WEI WANG | Strahlentherapie und Onkologie | 27 | 24 | |
2013 | An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma | Le Q.-T.; Zhang Q.; Cao H.; Cheng A.-J.; Pinsky B.A.; RUEY-LONG HONG ; Chang J.T.; CHUN-WEI WANG ; Tsao K.-C.; Lo Y.M.D.; Lee N.; Ang K.K.; Chan A.T.C.; Chan K.C.A. | Clinical Cancer Research | 135 | 119 | |